Trimetazidine reduces oxidative stress in cardiac surgery

Circulation Journal

Volumn 70, Issue 9, 2006, Pages 1169-1173

  Iskesen, Ihsan ^a   Saribulbul, Osman ^a   Cerrahoglu, Mustafa ^a   Var, Ahmet ^a   Nazli, Yunus ^a   Sirin, Hayrettin ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Free radicals; Ischemia reperfusion; Trimetazidine

Indexed keywords

ANTIOXIDANT; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRIMETAZIDINE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CELL MEMBRANE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; HEART SURGERY; HEMODYNAMICS; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; PREOPERATIVE TREATMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTIOXIDANTS; CORONARY ARTERY BYPASS; FEMALE; HEART ARREST, INDUCED; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 33748662905     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.1169     Document Type: Article

References (29)

1. Maxwell SR, Lip GY. Reperfusion injury: A review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 1997; 58: 95-117.
2. Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 2000; 47: 446-456.
3. Wattanapitayakul SK, Bauer JA. Oxidative pathways in cardiovascular disease: Roles, mechanisms, and therapeutic implications. Pharmacol Ther 2001; 89: 187-206.
4. Kara AF, Demiryurek S, Celik A, Tarakcioglu M, Demiryurek AT. Effects of trimetazidine on myocardial preconditioning in anesthetized rats. Eur J Pharmacol 2004; 503: 135-145.
5. Di Pasquale P, Lo Verso P, Bucca V, Cannizzaro S, Scalzo S, Maringhini G, et al. Effects of trimetazidine administration before thrombolysis in patients with anterior myocardial infarction: Short-term and long-term results. Cardiovasc Drugs Ther 1999; 13: 423-428.
6. Shlyakhto EV, Almazov VV, Nifontov EM, Vakhrameyeva IV, Rudomanov OG, Zakharov DV, et al. Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris. Am J Cardiovasc Drugs 2002; 2: 119-124.
7. Sun Y, Oberley LW, Ying L. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
8. Durak I, Yurtaslan Z, Canbolat O, Akyol O. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clin Chim Acta 1993; 214: 103-104.
9. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
10. Khan TA, Bianchi C, Voisine P, Feng J, Baker J, Hart M, et al. Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest. J Thorac Cardiovasc Surg 2004; 128: 602-608.
11. Hayasaki T, Kaikita K, Okuma T, Yamamoto E, Kuziel, Ogawa H. CC chemokine receptor-2 deficiency attenuates oxidative stress and infarct size caused by myocardial ischemia-reperfusion in mice. Circ J 2006; 70: 342-351.
12. Miwa K, Igawa K, Nakagawa K, Hirai T, Inoue H. Consumption of vitamin E in coronary circulation in patients with variant angina. Cardiovasc Res 1999; 41: 291-298.
13. Tsutsui H. Novel pathophysiological insight and treatment strategies for heart failure. Circ J 2004; 68: 1095-1103.
14. Maxwella SR, Lip GY. Reperfusion injury: A review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 1997; 58: 95-117.
15. Tanriverdi H, Evrengul H, Kuru O, Tanriverdi S, Seleci D, Enli Y. Cigarette smoking induced oxidative stress may impair endothelial function and coronary blood flow in angiographically normal coronary arteries. Circ J 2006; 70: 593-599.
16. Folden DV, Gupta A, Sharma AC, Li SY, Saari JT, Ren J. Malondialdehyde inhibits cardiac contractile function in ventricular myocytes via a p38 mitogen-activated protein kinase-dependent mechanism. Br J Pharmacol 2003; 139: 1310-1316.
17. Chen Z, Oberley TD, Ho Y, Chua CC, Siu B, Hamdy RC, et al. Overexpression of CuZnSOD in coronary vascular cells attenuates myocardial ischemia/reperfusion injury. Free Radic Biol Med 2000; 29: 589-596.
18. Tripathi Y, Hegde BM, Raghuveer CV. Effect of superoxide dismutase and acidified sodium nitrite on infarct size following ischemia and reperfusion in dogs. Indian J Physiol Pharmacol 1997; 41: 248-256.
19. Haramaki N, Stewart DB, Aggarwal S, Ikeda H, Reznick AZ, Pocker L. Networking antioxidants in the isolated rat heart are selectively depleted by ischemia-reperfusion. Free Radic Biol Med 1998; 25: 329-339.
20. Temsah RM, Netticadan T, Chapman D, Takeda S, Mochizuki S, Dhalla NS. Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart. Am J Physiol 1999; 277: 584-594.
21. Tossios P, Bloch W, Huebner A, Raji MR, Dodos F, Klass O, et al. N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: Results of a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 2003; 126: 1513-1520.
22. Shiomi T, Tsutsui H, Matsusaka H, Murakami K, Hayashidani S, Ikeuchi M, et al. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 2004; 109: 544-549.
23. Lopaschuk GD, Barr R, Thomas PD, Dyck JR. Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase. Circ Res 2003; 93: 33-37.
24. Singh D, Chopra K. Effect of trimetazidine on renal ischemia/reperfusion injury in rats. Pharmacol Res 2004; 50: 623-629.
25. Barsotti A, Di Napoli P. Trimetazidine and cardioprotection during ischemia-reperfusion. Ital Heart J 2004; 5: 29-36.
26. Stanley WC, Marzilli M. Metabolic therapy in the treatment of ischaemic heart disease: The pharmacology of trimetazidine. Fundam Clin Pharmacol 2003; 17: 133-145.
27. Tunerir B, Colak O, Alatas O, Besogul Y, Kural T, Aslan R. Measurement of troponin T to detect cardioprotective effect of trimetazidine during coronary artery bypass grafting. Ann Thorac Surg 1999; 68: 2173-2176.
28. Wang J, Huang YW, Wei JH, Wei TX, Dong JZ, Zhang JY. Protective effect of trimetazidine on rabbit myocardium during ischemia-reperfusion (abstract). Zhejiang Da Xue Xue Bao Yi Xue Ban 2003; 32: 219-222.
29. McClellan KJ, Plosker GL. Trimetazidine: A review of its use in stable angina pectoris and other coronary conditions. Drugs 1999; 58: 143-157.